MA53904A - Composés contenant du deutérium - Google Patents

Composés contenant du deutérium

Info

Publication number
MA53904A
MA53904A MA053904A MA53904A MA53904A MA 53904 A MA53904 A MA 53904A MA 053904 A MA053904 A MA 053904A MA 53904 A MA53904 A MA 53904A MA 53904 A MA53904 A MA 53904A
Authority
MA
Morocco
Prior art keywords
compounds containing
containing deuterium
deuterium
compounds
Prior art date
Application number
MA053904A
Other languages
English (en)
Inventor
Fredrik Lehmann
Original Assignee
Oncopeptides Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB1816998.7A external-priority patent/GB201816998D0/en
Priority claimed from GBGB1909695.7A external-priority patent/GB201909695D0/en
Application filed by Oncopeptides Ab filed Critical Oncopeptides Ab
Publication of MA53904A publication Critical patent/MA53904A/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06191Dipeptides containing heteroatoms different from O, S, or N
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F13/00Compounds containing elements of Groups 7 or 17 of the Periodic System
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/05Isotopically modified compounds, e.g. labelled
MA053904A 2018-10-18 2019-10-17 Composés contenant du deutérium MA53904A (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB1816998.7A GB201816998D0 (en) 2018-10-18 2018-10-18 Compounds
GBGB1909695.7A GB201909695D0 (en) 2019-07-05 2019-07-05 Compounds

Publications (1)

Publication Number Publication Date
MA53904A true MA53904A (fr) 2021-08-25

Family

ID=68290247

Family Applications (1)

Application Number Title Priority Date Filing Date
MA053904A MA53904A (fr) 2018-10-18 2019-10-17 Composés contenant du deutérium

Country Status (19)

Country Link
US (1) US20210388024A1 (fr)
EP (1) EP3866931B1 (fr)
JP (1) JP2022512736A (fr)
KR (1) KR20210078487A (fr)
CN (1) CN112930214A (fr)
AU (1) AU2019362389A1 (fr)
BR (1) BR112021007060A2 (fr)
CA (1) CA3116198A1 (fr)
DK (1) DK3866931T3 (fr)
ES (1) ES2942468T3 (fr)
FI (1) FI3866931T3 (fr)
HU (1) HUE061801T2 (fr)
IL (1) IL282231A (fr)
MA (1) MA53904A (fr)
MX (1) MX2021004474A (fr)
PL (1) PL3866931T3 (fr)
SG (1) SG11202103726RA (fr)
WO (1) WO2020079165A1 (fr)
ZA (1) ZA202102492B (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201905477D0 (en) * 2019-04-17 2019-05-29 Oncopeptides Ab Novel formulations
EP4347615A1 (fr) * 2021-06-01 2024-04-10 Synthon B.V. Procédé de préparation de melflufène ou d'un sel de celui-ci
GB202109895D0 (en) 2021-07-08 2021-08-25 Oncopeptides Ab Novel treatments
WO2023281007A1 (fr) 2021-07-08 2023-01-12 Oncopeptides Ab Melflufène destiné à être utilisé dans le traitement du myélome multiple
GB202109894D0 (en) 2021-07-08 2021-08-25 Oncopeptides Ab Novel treatments
GB202109896D0 (en) 2021-07-08 2021-08-25 Oncopeptides Ab Novel treatments
GB202204171D0 (en) 2022-03-24 2022-05-11 Oncopeptides Ab Novel formulations

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0002202D0 (sv) 2000-06-13 2000-06-13 Karolinska Innovations Ab New peptides
AU2009303758B8 (en) 2008-09-18 2015-02-19 Auspex Pharmaceuticals, Inc. Benzoquinoline inhibitors of vesicular monoamine transporter 2
US20140128462A1 (en) * 2011-04-28 2014-05-08 Oncopeptides Ab Lyophilized preparation of cytotoxic dipeptides
US10285946B2 (en) * 2012-10-26 2019-05-14 Oncopeptides Ab Lyophilized preparations of melphalan flufenamide
BR112015016889A8 (pt) * 2013-02-05 2018-01-23 Imphar Ag derivados de catecolamina enriquecidos com deutério em posição específica
CN104725380B (zh) * 2013-12-18 2019-06-28 康塞特医药品有限公司 卢索替尼的氘代衍生物
GB201507903D0 (en) 2015-05-08 2015-06-24 Oncopeptides Ab Process for preparation of nitrogen mustard derivatives
GB201521217D0 (en) * 2015-12-01 2016-01-13 Oncopeptides Ab Dosage regimens

Also Published As

Publication number Publication date
EP3866931B1 (fr) 2023-02-15
US20210388024A1 (en) 2021-12-16
MX2021004474A (es) 2021-08-24
FI3866931T3 (fi) 2023-05-10
CA3116198A1 (fr) 2020-04-23
PL3866931T3 (pl) 2023-06-19
ES2942468T3 (es) 2023-06-01
BR112021007060A2 (pt) 2021-07-20
AU2019362389A1 (en) 2021-06-03
DK3866931T3 (da) 2023-04-24
ZA202102492B (en) 2024-04-24
HUE061801T2 (hu) 2023-08-28
WO2020079165A1 (fr) 2020-04-23
IL282231A (en) 2021-05-31
KR20210078487A (ko) 2021-06-28
EP3866931A1 (fr) 2021-08-25
CN112930214A (zh) 2021-06-08
SG11202103726RA (en) 2021-05-28
JP2022512736A (ja) 2022-02-07

Similar Documents

Publication Publication Date Title
MA53904A (fr) Composés contenant du deutérium
MA52489A (fr) Nouveaux composés
MA51530A (fr) Composés cycliques fondus
MA44233A (fr) Nouveaux composés
MA50567A (fr) Nouveaux composés de sulfonamide carboxamide
MA49901A (fr) Nouveaux composés de sulfonamide carboxamide
MA49904A (fr) Nouveaux composés de sulfonamide carboxamide
MA56075A (fr) Nouveaux composés de sulfonamide carboxamide
MA47576A (fr) Composés inhibiteurs d'oga bicyclique
DK3692040T3 (da) Kemiske forbindelser
MA47131A (fr) Composés benzyl-amide phosphodiamide antiviraux
MA44050A (fr) Nouveaux composés
MA52948A (fr) Composés
MA52967A (fr) Composés antagonistes du pcsk9
MA51669A (fr) Composés
MA54407A (fr) Composés de co-agonistes du glucagon et du glp-1
MA43512A (fr) Composés hétérocycliques utiles en tant que modulateurs du tnf alpha
MA52942A (fr) Composés inhibiteurs d'oga
MA52939A (fr) Composés inhibiteurs d'oga
MA53003A (fr) Composés
MA47420A (fr) Composés inhibiteurs d'oga
MA45221A (fr) Nouveaux composés antibactériens
MA49623A (fr) Composés chimiques
MA49522A (fr) Nouveaux composés de quinoléinone
MA53430A (fr) Nouveaux composés